Warburg Pincus, the global private equity firm focused on growth investing, closed Warburg Pincus China-Southeast Asia II, L.P., at $4.25 billion.
Haoqipei, a Shangai, China-based Business-to-business (B2B) auto parts trading platform, closed US $60m in Series D financing.
GT Apeiron Therapeutics, a Shanghai, China-based biotech company utilizing technologies for drug discovery, raised $27m in funding.
Oncologie, a Boston, MA- and Shanghai, China-based oncology therapeutics company, closed an $80M Series B financing.
EpimAb Biotherapeutics, a Shanghai, China-based biopharmaceutical company specializing in bispecific antibodies, closed a $74m USD Series B financing round.
Alphamab Oncology, a Suzhou, China-based biopharmaceutical company dedicated to global development of innovative biologics for cancer therapy, completed a US$60m Series B financing.
Venture capital firm Panacea Venture raised over $180.5k for its first healthcare fund.
Mafengwo, a Beijing, China-based online travel platform, raised $250m in funding.
Jiuye Supply Chain Management, a Shangai, China-based cold chain service provider, closed a Series C+ funding round of undisclosed amount.
Lingxi AR, a Beijing, China-based manufacturer of AR optical waveguide module, raised a financing of tens of millions yuan from A+ round.
BrandHouse Holdings Limited, a London, UK-based online platform for fast moving consumer goods, raised €4m in Series A funding.
GeneQuantum Healthcare, a Suzhou, China-based developer of bioconjugate drugs, closed nearly RMB 100 million Pre-B round of financing.
QTC Care, a Beijing, China-based health care company, closed an approx. $7m series A financing.
Gen.G, a Los Angeles, CA-based premier global esports organization, raised $46m in funding.
Minieye, a Beijing, China-based company developing sensing system of autonomous driving, completed its Series B financing and received hundreds of millions of credit lines.